CIA CPIA - Kimia Farma Head Audit

All Insiders . Indonesia . 
Stock . Kimia Farma Persero . Stakeholders . Insider . CIA CPIA
KAEF Stock  IDR 635.00  5.00  0.78%   

Insider

CIA CPIA is Head Audit of Kimia Farma Persero
Phone62 21 384 7709
Webhttps://kimiafarma.co.id

Kimia Farma Management Efficiency

Kimia Farma's management efficiency ratios could be used to measure how well Kimia Farma manages its routine affairs as well as how well it operates its assets and liabilities.
Kimia Farma Persero has accumulated 3.25 T in total debt with debt to equity ratio (D/E) of 1.09, which is about average as compared to similar companies. Kimia Farma Persero has a current ratio of 0.99, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Kimia Farma until it has trouble settling it off, either with new capital or with free cash flow. So, Kimia Farma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kimia Farma Persero sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kimia to invest in growth at high rates of return. When we think about Kimia Farma's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Amelia HendraSiloam International Hospitals
N/A
Sri NovaniSumber Alfaria Trijaya
N/A
Gunawan PrajitnoSiloam International Hospitals
49
Andya DaniswaraElang Mahkota Teknologi
N/A
Ryan KalohSumber Alfaria Trijaya
N/A
Catherine SabatiniSiloam International Hospitals
31
Darjoto BScSiloam International Hospitals
65
Mudunsen PutraSumber Alfaria Trijaya
N/A
MBA MBAMitra Keluarga Karyasehat
53
MariaSiloam International Hospitals
N/A
SE MMMitra Keluarga Karyasehat
43
Sri DewiElang Mahkota Teknologi
N/A
Mochtar RiadySiloam International Hospitals
93
Giatrycks SianiparElang Mahkota Teknologi
48
Joel EllisSiloam International Hospitals
37
Saka NainggolanElang Mahkota Teknologi
N/A
Nur RachmanSumber Alfaria Trijaya
N/A
Tri SunuSumber Alfaria Trijaya
51
Paulus SujonoSiloam International Hospitals
N/A
PT Kimia Farma Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia, rest of Asia, Europe, Australia, Africa, and New Zealand. The company was founded in 1817 and is headquartered in Jakarta, Indonesia. Kimia Farma operates under Drug ManufacturersSpecialty Generic classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 11772 people. Kimia Farma Persero (KAEF) is traded on Jakarta Exchange in Indonesia and employs 11,511 people.

Management Performance

Return On Equity-0.026
Return On Asset0.0089

Kimia Farma Persero Leadership Team

Elected by the shareholders, the Kimia Farma's board of directors comprises two types of representatives: Kimia Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kimia. The board's role is to monitor Kimia Farma's management team and ensure that shareholders' interests are well served. Kimia Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kimia Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pujianto, Business Development Director
David Utama, Pres Director
I Wijaya, Finance Director
Jasmine Karsono, RD Marketing
Nurrachman, Independent Commissioner
CIA CPIA, Head Audit
Arief Pramuhanto, Human Capital and General Affairs Director
Honesti Basyir, President Director
Ganti Putro, Corporate Secretary
Dharma MM, HR Director
Verdi Budidarmo, Production and Supply Chain Director
Lina MM, F Director
MM Apt, Director Director
Untung Sutarjo, President Commissioner
Wahono Sumaryono, Independent Commissioner
Chrisma Albandjar, Commissioner
Eva Fairus, Gen Sales
Muhammad Fauzi, Commissioner
Rosrini, Compliance Mang

Kimia Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kimia Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.026
Return On Asset0.0089
Profit Margin(0.02) %
Operating Margin0.03 %
Current Valuation14.62 T
Shares Outstanding5.55 B
Shares Owned By Insiders95.80 %
Shares Owned By Institutions0.07 %
Price To Book0.90 X
Price To Sales0.60 X

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Kimia Stock

Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY